CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Powder HMF +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02632266
NCT02632266Phase 4Completed
CompareCT.gov

Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants

University of Kansas Medical Center·interventional·Posted Dec 16, 2015·Updated Sep 3, 2020

In Brief

A Phase 4 clinical trial evaluating Powder HMF and Liquid HMF for Complication of Prematurity. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is for the researchers to examine the safety and efficacy of liquid human milk fortifier (HMF) in moderately preterm infants compared to powdered human milk fortifier.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsComplication of Prematurity
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 16, 2015
Enrollment StartJul 1, 2015
Primary CompletionMay 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.5 years ago

Interventions

Powder HMFdietary

powder human milk fortifier

Liquid HMFdietary

Liquid human milk fortifier